New clinical study to evaluate QuickMIC® in the diagnostic workflow of urosepsis
Uppsala, Sweden, March 5, 2024. The diagnostics company Gradientech today announces the start of a new prospective and observational QuickMIC® study in collaboration with Assoc. Prof. Martin Sundqvist at Örebro University Hospital.The study, initiated by Dr Sundqvist, will investigate the clinical utility of a new rapid workflow for prediction of optimal antibiotic treatment for patients with urosepsis. Urosepsis is caused by infections of the urinary tract where the sepsis causing bacteria are hence present in the urine and often, but not always, also in the patient’s blood. Results